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Background: Cervical cancer is the leading cause of cancer related deaths among women in Nepal. The long
symptom to diagnosis interval means that women have advanced disease at presentation. The aim of this study
was to identify, estimate and describe the extent of different delays in diagnosis of cervical cancer in Nepal.
Methods: A cross-sectional descriptive study was conducted in two tertiary cancer hospitals of Nepal. Face to face
interview and medical records review were carried out among 110 cervical cancer patients. Total diagnostic delay
was categorized into component delays: patient delay, health care providers delay, referral delay and diagnostic
waiting time.
Results: Total 110 patients recruited in the study represented 40 districts from all three ecological regions of the
country. Median total diagnostic delay was 157 days with more than three fourth (77.3%) of the patients having
longer total diagnostic delay of >90 days. Out of the total diagnostic delay, median patient delay, median health
care provider delay, median referral delay and median diagnostic waiting time were 68.5 days, 40 days, 5 days and
9 days respectively. Majority of the patients had experienced longer delay of each type except referral delay. Fifty
seven percent of the patients had experienced longer patient delay of >60 days, 90% had suffered longer health
care provider delay of >1 week, 31.8% had longer referral delay of >1 week and 66.2% had waited >1 week at
diagnostic center for final diagnosis. Variation in each type of delay was observed among women with different
attributes and in context of health care service delivery.
Conclusions: Longer delays were observed in all the diagnostic pathways except for referral delay and diagnostic
waiting time. Among the delays, patient delay is of crucial importance because of its longer span, although health
care provider delay is equally important. In the context of limited screening services in Nepal, the efforts should be
to reduce the diagnostic delay especially patient and health care provider delay for early detection and reduction
of mortality rate of cervical cancer.
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Cervical cancer is the third most commonly diagnosed
cancer in women worldwide with more than 85.0% bur-
den in developing countries [1]. Although, cervical can-
cer can be cured if detected at earlier stage [2,3], it
continues to be a major public health threat to women
in Nepal where it is still the leading cancer with high
morbidity and mortality [1,4]. With an incidence rate of
32 per 100,000 per annum and mortality about 18 per* Correspondence: deepaknu@gmail.com
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stated.100,000 per annum it accounts 21.0% of total female
cancer in Nepal [5,6].
One of the most important prognostic factors for cer-
vical cancer is how early the disease is detected and how
far it has spread [7,8]. Early diagnosis of cancer results
in lower stages of the cancer, less intensive treatment
and improved survival [7,9,10]. In Nepal, most of the
cervical cancer patients have been reported diagnosed at
advanced stage [11,12] indicating the long duration be-
tween disease onset and final diagnosis of the disease.
Diagnostic delay covers the period from the patient’s
first experience of symptoms until diagnosis [13]. Redu-
cing diagnostic delay may increase the proportion ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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occur at different stages of the cancer diagnostic journey
and have been commonly defined as being either patient
focused or healthcare provider focused [7,13]. Com-
monly, delay is found further categorized into different
component delays such as patient delay, health care pro-
vider delay, referral delay and system delay [7,13,14]. De-
lays are calculated on the basis of dates provided by the
patients and/or health care providers. Each type of de-
lays have been found influenced by different conditions
and characteristics related to either patients or health
care providers or service delivery system [13,15-19].
Knowledge of delays is crucial in cancer prevention
and control and it has been the subject of research for
decades in developed countries. In Nepal, this issue has
not been given much of importance and there is lack of
researches related to this issue. The aim of this study
was to identify, estimate and describe the extent of dif-
ferent delays in cervical cancer diagnosis in Nepalese
context.Operational definitions
Symptoms
Symptoms were defined as any patient’s complaints that
led to a diagnosis of cervical cancer and included foul
smelling vaginal discharge, lower abdominal pain, back
ache and abnormal bleeding per vaginum.Patient delay
The time period from a patient first becoming aware of
symptoms till their first presentation to a health care
provider (HCP). The duration of more than 60 days was
defined as “long patient delay” and 60 days or less was
defined as “short patient delay” [13].Health care provider’s (HCP) delay
The time period between patient’s first presentation to
the health care provider (HCP) and the final referral by
HCP to the cancer diagnostic center. The period of
seven days or less was defined as “short HCP delay” and
more than seven days was referred as “long HCP delay”.Referral delay
The time interval between the date of final referral by
health care provider to diagnostic center with suspicion
of cervical cancer and the date of first appointment of
patient in the cervical cancer diagnostic center. The
period of seven days or less was defined as “short refer-
ral delay” and more than seven days was referred as
“long referral delay”. Actually, it is patient’s decision
making period and the travel period to reach the diag-
nostic center after referral by HCP.Diagnostic waiting time
This includes waiting time for all relevant investigations of
symptoms in the diagnostic center. The period of seven
days or less was defined as “short waiting time” and more
than seven days was defined “long waiting time”.
Total diagnostic delay
The time period between onset of symptoms of cervical
cancer and confirmed diagnosis. The period of more
than 90 days was defined as “long diagnostic delay” and
90 days or less as “short diagnostic delay” [20].
[Total diagnostic delay = patient delay + health care
provider delay + referral delay + diagnostic waiting time.]
In this study, the term “delay” refers to the time inter-
val between two specific events in diagnostic pathway.
Because there is no standard cutoff point to dichotomize
the interval into “short delay” and “long delay; and it is
contextual, such cutoff points for different delays were
defined in context of socio-cultural aspect, health seek-
ing behavior of women and health care system of Nepal.
Methods
A cross- sectional descriptive study was carried out at
two cancer hospitals of Nepal: B.P. Koirala memorial
cancer hospital (BPKMCH), Bharatpur, Chitwan and
Bhaktapur cancer hospital, Bhaktapur from August to
October, 2012. These are the only two referral cancer
hospitals which cater the most of the cancer diagnosis
and treatment services in Nepal [11]. Nepali women di-
agnosed of cervical cancer for the first time and attend-
ing the hospitals during study period were included in
the study. Critically ill and patients diagnosed outside
Nepal were excluded. Numbers of participants were se-
lected proportionately on the basis of case load in hos-
pitals. According to hospital records, 505 cases in
BPKMCH and 122 cases in Bhaktapur cancer hospital
were diagnosed of cervical cancer in 2010. Out of 110
sample cases, 90 cases were taken from BPKMCH and
20 cases from Bhaktapur cancer hospital. To reduce se-
lection bias, data collection was done on alternate days
during study period. Cervical cancer patients attending
to the hospitals were identified from the registration de-
partment in each day of data collection. Then all the
available patients meeting the inclusion criteria were in-
vited to participate in the study. Face to face interview
with patients was conducted using pre-tested structured
questionnaire for the socio-demographic information
and information on history of diagnostic journey. Pa-
tient’s medical documents were reviewed for supplemen-
tary information regarding different dates in diagnosis.
The concept of delay in diagnostic journey and ways
of inquiring illness history of patients is elaborated in
Figure 1. Dates used for estimating delays were date of
symptoms experienced, date of first consultation with
A= Date of symptom experienced by women (onset of symptoms)
B= Date of first contact with HCP
C= Date of referral by HCP to diagnostic center
D= Date of first visit to diagnostic center
E= Date of diagnosis
F= Date of treatment initiation
B-A = Patient delay
C- B= HCP delay
D-C= Referral delay
E-D = Diagnostic waiting time
E-A= Total diagnostic delay
A B C D E F
Diagnostic journey
Inquiry of Illness history 
Figure 1 Concept of delays and way of history taking.
Gyenwali et al. BMC Women's Health 2014, 14:29 Page 3 of 9
http://www.biomedcentral.com/1472-6874/14/29health care provider (HCP), date of final referral to can-
cer diagnostic center by HCP, date of first visit to cancer
diagnostic center and date of confirmed diagnosis. The
illness history was taken in a retrospective manner start-
ing from the most recent event in diagnostic pathway
i.e. date of diagnosis or treatment initiation of cervical
cancer and probing backward without interruption until
the information about the type and date of symptoms
experienced (Figure 1). If the patients were unable to re-
call the exact date of symptoms experienced and date of
first consultation with HCP, such dates were approxi-
mated by probing the exact week of the respective
month and year of symptoms experienced and first con-
sultation with HCP. The mid-point of that week was ap-
proximated as date of symptoms experienced and date
of first consultation with HCP accordingly. Analysis of
data was done by using computer software SPSS 18.0
version. Delays in diagnosis were measured in terms of
continuous variables i.e. days.
Interviewers explained the participants the purpose of
the study, obtained informed consent from the eligible
participants and interviewed them individually in a sep-
arate room. The study protocol and questionnaire were
approved for ethical clearance by the board of thesis
committee of Institute of Medicine, Tribhuvan Univer-
sity. In addition, permission was obtained from both
hospitals before starting the study.Results
Characteristics of the patients of cervical cancer
Out of 75 districts of Nepal, the study participants had
represented 40 districts of all three ecological regions:
plain, hill and mountain. Among the participants, 75
women were diagnosed in cancer hospitals and 35
women in other hospitals of Nepal. Selected characteris-
tics of the research participants are presented in Table 1.
The mean age of the participants was 52.72 years (SD =
10.63), the youngest patient was 27 years and the oldest
79 years. Two third (66.4%) of the patients were illiterate
and most of them (77.3%) were from rural areas. Eighty
percent of the participants were currently married and
living together while 20.0% were widows. The mean par-
ity of the women was 4.85 (SD = 2.57) having minimum
one and maximum thirteen children. More than half of
the participants (57.3%) were from terai (plain) region
and rest from hilly and mountain regions. More than two
third (68.2%) of the patients had travelled more than four
hours, with available means of transportation, to reach the
diagnostic center. The median travel time to reach the
place of diagnosis for cervical cancer was five hours having
range from one to 36 hours from patient’s residence.
Diagnostic journey of patients
Table 2 presents the diagnostic journey of cervical can-
cer patients. The common earlier symptoms were foul




Age at diagnosis (in years)
Less than 50 41 37.3
50 or more 69 62.7









Married and living together 88 80.0
Widow 22 20.0
Parity
≤3rd parity 35 31.8
> 3rd parity 75 68.2
Mean Parity ± S.D. = 4.85 ± 2.57, range 1-13
Ecological region of residence
Terai (plain) 63 57.3
Hills and mountain 47 42.7
Remoteness of place of diagnosis (travel time in Hours)
<4 35 31.8
≥4 75 68.2
Median travel time = 5 hrs, range 1-36 hrs
Table 2 Description of the history of diagnostic journey
of cervical cancer patients
Characteristics Number (n) Percentage
Type of earlier symptom
Foul smelling PV discharge 60 54.5
Lower abdominal pain 25 22.7
Abnormal PV bleeding 25 22.7
Chief complaints to consult HCP
Foul smelling PV discharge 19 17.3
Lower abdominal pain 22 20.0
Abnormal PV bleeding 69 62.7
Type of first contact health facilities
SHP/HP/PHC 20 18.2
Private medical shops 37 33.6
Government Hospital 19 17.3
Private hospitals 34 30.9
Number of HFs contacted before being referred to cancer diagnostic center
Single HF 14 12.7
2-3 HFs 76 69.1
>3 HFs 20 18.2
Mean ± S.D. = 2.7 ± 1.07, range 1-6
Number of pre-referral consultations in different HFs
≤ 3 19 17.3
>3 91 82.7
Mean ± S.D. = 4.77 ± 1.8, range 1-10
Cervical/per speculum examination in initial consultation
Yes 24 21.8
No 86 78.2
Symptoms misinterpretation in initial consultation with HCP
No 11 10.0
Yes 99 90.0
Number of visits in cancer diagnostic center till diagnosis
≤ 2 visits 55 50.0
>2 visits 55 50.0
Mean ± S.D. = 2.65 ± 0.77, range 2-5
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normal PV bleeding including post coital bleeding (PCB),
inter- menstrual bleeding (IMB) and post- menopausal
bleeding (PMB). Although, more than half (54.5%) of the
patients had foul smelling vaginal discharge as the earliest
symptom, abnormal vaginal bleeding was the major chief
complaint (62.7%) of women that led them to consult a
health care provider (HCP) for the first time.
Private medical shops (33.6%) and private hospitals
(30.9%) were the main primary contact point with a
health care provider for the patients. Government’s com-
munity level health facilities: Sub-Health Post/Health
Post/Primary Health Center (SHP/HP/PHC) and hospi-
tals were reported as the primary contact point only in
18.2% and 17.3% respectively. In average women had
consulted about three different health facilities and most
of them (82.7%) had more than three pre-referral con-
sultations with HCP.
Cervical examination was not performed in more than
three fourth (78.2%) and most of their (90.0%) symptoms
were misinterpreted in initial consultation with HCP.The average number of pre-diagnostic visits of the
patients in cervical cancer diagnostic center was 2.65
(SD = 0.77) with range two to five. The clinical staging of
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system update 2009 [21]. Only 19% of the patients were
diagnosed in early stage (≤IIA) and rest were in advan-
taged stage (≥IIB).
Estimates of delays in diagnosis
The median patient delay was 68 days with long patient
delay in 57% of the patients. Similarly, median HCP
delay was 40 days with 80.9% patients having long HCP
delay. The referral delay was found comparatively low
(median 5 days) with more than two third (68.2%) hav-
ing short referral delay. After the first visit to diagnostic
center, two third (66.2%) of the patients had to wait
more than one week for diagnosis of cervical cancer
(median diagnostic waiting time of nine days). The me-
dian value of total diagnostic delay was 157 days with
longer total diagnostic delay in 77.3% of patients
(Table 3).
Table 3 presents the details of patient delay, health
care provider delay, referral delay, diagnostic waiting
time and total diagnostic delay distribution according to
selected patient’s characteristics and other attributes.
The long total diagnostic delay (>90 days) was observed
more among patients aged 50 years or more (81.2%),
illiterate (82.2%) and those residing at remote places
(82.7%). Long patient delay (median 71.5 days) and total
diagnostic delay (median 199 days) were found in pa-
tients with early symptoms like foul smelling vaginal dis-
charge as compared to patients with other symptoms.
The longer total diagnostic delay was also higher (88.3%)
among these women. Cent percent longer health care
provider’s delay with median 69 days and higher propor-
tion of total diagnostic delay (89.5%) with median delay
of 215 days was observed among patients who consulted
HCP for the first time with chief complaint of foul
smelling vaginal discharge. These statistics were com-
paratively lower among patients with chief complaints of
pelvic pain and abnormal vaginal bleeding. Similarly,
longer HCP delay (median 72.5 days) and total diagnos-
tic delay (median 214 days) were observed among
women whose primary contact point was community
level health (SHP/HP/PHC). Higher proportion of HCP
delay (96.7%) and total diagnostic delay (79.1%) were
measured among patients who had more than three pre-
referral consultations. The HCP delay and total diagnos-
tic delay were found higher among the patients whose
cervix was not examined in initial consultation.
Discussion
This study identified different lag periods in diagnosis of
cervical cancer, total diagnostic delay categorized into
patient delay, healthcare provider delay, referral delay and
diagnostic waiting time. Although, no standardized defin-
ition of delay is found, the studies on diagnostic delayshave several common themes regarding the length of delay
based on dates of important events in diagnostic journey
of the patients [7,13,14,20]. Similar type of component de-
lays of cancer diagnosis have been applied in previous
studies [13,14,22]. Variation can be found in the point of
dichotomization of each type of delay into long and short
delay but it is very contextual [9,13,23-25]. Hansen has
categorized delays as short or long based on quartiles and
described delays in terms of median and inter-quartile
range [13]. Other studies have considered certain time pe-
riods such as days, weeks or months for this purpose
[20,23-26].
This study revealed the median patient delay of
68.5 days, median health care provider delay of 40 days,
median referral delay of 5 days, median diagnostic time
of 9 days and median total diagnostic delay of 157 days.
This diagnostic delay was found higher in Nepal when
compared with that of developed countries [24,26]. High
prevalence of long diagnostic delay of more than three
months maybe extremely unacceptable if cancer is to be
treated in early stage. The longer duration of symptoms
till diagnosis supports the high prevalence of late stage
diagnosis of cervical cancer in Nepal [11,12]. Patient and
health care provider delay accounted for most of the
total delay. As a major delay, Nepalese women had
suffered longer patient delay with the wide range of 8 –
404 days, as compared to other delays. The longer
patient delay in Nepal may have resulted due to the in-
fluence of patient’s characteristics such as high level of
illiteracy, poor health awareness, poor economic condi-
tion, their problematic health seeking behavior, ignoring
the mild gynecological symptoms as well as dependency
on traditional health care practices [9,12]. Previous stud-
ies have also revealed that the patient’s behavior of not
recognizing symptom seriousness and rather ignoring
them as the factors for increasing patient delay in diag-
nosis of cervical cancer [9,23]. In some population,
prevalent symptom like vaginal discharge is not recog-
nized as warning symptom and in most cases medical
assistance is not sought until it becomes obvious and
unbearable, eventually leading to longer patient delay
and total diagnostic delay [27,28].
This study establishes the fact that health care pro-
vider’s delay as another major delay in cervical cancer
diagnosis. Although in low proportion, longer medical
delay have also been observed in previous studies, even
in developed countries [13,23]. The observation of med-
ical delay in Morrocco where 61% of patients had suf-
fered ≥30 days’ delay was similar to that of Nepal. The
high proportion of health care provider delay in Nepal
can be argued from various perspectives such as access
to services, education level of health care providers and
existing health care system and policy. In Nepal, the first
contact point like the sub-health post (SHP) and health
Table 3 Extent of patient delay, health care provider delay, referral delay, diagnosis waiting time and total diagnostic delay in cervical cancer diagnosis by
selected patient characteristics and other attributes










































Less than 50 66 (8-306) 20 (48.8) 21 (51.2) 41 (0-372) 1 (2.4) 40 (97.6) 5 (0-49) 27 (65.9) 14 (34.1) 8 (3-40) 18 (43.9) 23 (56.1) 148 (36-622) 12 (29.3) 29 (70.7)
Fifty or more 71 (8-404) 27 (39.1) 42 (60.1) 39 (0-582) 10 (14.5) 59 (85.5) 5 (0-88) 48 (69.6) 21 (34.4) 9 (2-57) 19 (27.5) 50 (72.5) 160 (22-718) 13 (18.8) 56 (81.2)
Education
Illiterate 72 (8-353) 27 (37.0) 46 (63.0) 41 (0-582) 6 (8.2) 67 (91.8) 5 (0-88) 46 (63.0) 27 (37.0) 9 (2-57) 23 (31.5) 50 (68.5) 158.7 (25-718) 13 (17.8) 60 (82.2)





48 (8-274) 19 (54.3) 16 (45.7) 16 (0-282) 5 (14.3) 30 (85.7) 2 (0-18) 30 (85.7) 5 (14.3) 8 (2-57) 15 (42.9) 20 (57.1) 123 (25-376) 12 (34.3) 23 (65.7)
Four hours
and more
72 (8-404) 28 (37.3) 47 (62.7) 49 (0-582) 6 (8.0) 69 (92.0) 6 (0-88) 45 (60.0) 30 (40.0) 9 (3-38) 22 (29.3) 53 (70.7) 177 (22-718) 13 (17.3) 62 (82.7)
Types of earlier
symptoms
Vaginal discharge 71.5 (8-404) 23 (38.3) 37 (61.7) 199 (25-622) 7 (11.7) 53 (88.3)
Pelvic pain 62 (9-239) 12 (48.0) 13 (52.0) 146 (36-718) 9 (36.0) 16 (64.0)
Abnormal
vaginal bleeding
65 (10-304) 12 (48.0) 13 (52.0) 106 (22-403) 9 (36.0) 16 (64.0)
Chief complaints
Vaginal discharge 69 (9-582) 0 (0.0) 19 (100.0) 215 (69-718) 2 (10.5) 17 (89.5)
Pelvic pain 38.5 (6-316) 1 (4.5) 21 (95.5) 144 (36-631) 5 (22.7) 17 (77.3)
Abnormal
vaginal bleeding
25 (0-372) 10 (14.5) 59 (85.5) 153 (22-622) 18 (26.1) 51 (73.9)
Type of first contact
health facilities
SHP/HP/PHC 72.5 (10-582) 0 (0.0) 20 (100.0) 214 (56-718) 4 (20.0) 16 (80.0)
Private medical shops 64 (7-316) 3 (8.1) 34 (91.9) 158 (48-631) 8 (21.6) 29 (78.4)
Government hospitals 38 (0-348) 3 (15.8) 16 (84.2) 142 (36-430) 5 (26.3) 14 (73.7)
Private hospitals 19 (0-217) 5 (14.7) 29 (85.3) 137 (22-374) 8 (23.5) 26 (76.5)
Pre-referral consultations
with HCP






















Table 3 Extent of patient delay, health care provider delay, referral delay, diagnosis waiting time and total diagnostic delay in cervical cancer diagnosis by
selected patient characteristics and other attributes (Continued)
More than three 49 (6-582) 3 (3.3) 88 (96.7) 160 (25-718) 19 (20.9) 72 (79.1)
Per-Speculum examination
in initial consultation
Yes 9.5 (0-151) 8 (33.3) 16 (66.7) 108 (22-428) 9 (37.5) 15 (62.5)
No 53.5 (6-582) 3 (3.5) 83 (96.5) 168 (36-718) 16 (18.6) 70 (81.4)
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at community level are run by health care providers
having basic medical trainings. These health workers
often lack competency on gynecological examination
and knowledge on cervical cancer screening and detec-
tion. In the existing health care system of Nepal, all
woman do not have access to gynecologists or medical
doctors for their gynecological symptoms [29]. This ar-
gument is in line with the findings that women had to
visit many health facilities for several times before being
finally referred to diagnostic center. The structure of
health care system, referral mechanism, socio-cultural
factors, knowledge level of health care provider and
asymmetric relationship between health care provider
and patients influence the health seeking practices of pa-
tients [30,31]. Inadequate knowledge of cervical cancer
etiology, alarming symptoms, screening, diagnostic pro-
cedure and treatment among health care practitioners
contribute in delays in diagnosis [16], eventually leading
to the misdiagnosis of cancer. Non-recognition of cer-
vical cancer symptoms and/or not being able to provide
a cervical examination by health care provider in initial
consultation creates the situation of unnecessary visits in
different health institutions [17,20]. Patients who com-
plained of alarming symptoms such as abnormal vaginal
bleeding or severe pelvic pain had faced shorter HCP
delay as compared to patients with other symptoms like
foul smelling vaginal discharge. Gynecological examin-
ation by the HCP has been observed to be performed
less often in woman without vaginal bleeding. The length
of the delay has been reported shortened in patients who
had gynecological examination by the HCP for complaints
of alarming symptoms [20].
The length and frequency distribution of each type of
diagnostic delays varied in different groups of partici-
pants. Elderly and illiterate women residing in remote
areas had longer patient delay, HCP delay, diagnostic
waiting time and total diagnostic delay in high propor-
tion. Studies have also revealed advanced age as a risk
factor of patient delay in cancer diagnosis including cer-
vical cancer [9,19,23]. Higher proportion of longer delays
in certain groups of patients depicts the barriers in
health care access and prolongation in delays in diagno-
sis among those population [23,28].
Conclusions
Delay in diagnosis is a major issue in cancer prevention,
treatment and control. Longer delays observed all over
the diagnostic pathway is of serious concern as this re-
sult in high prevalence of advanced stage at diagnosis
and high mortality. Among the delays, patient delay is of
crucial importance because of its longer span; however
health care provider delay is equally important. Thus,
education of both the patient and health care providersis essential for early diagnosis. There is a need of com-
prehensive approach to address two major delays: pa-
tient delay and health care provider (HCP) delay by
increasing the patient’s awareness, enhancing the health
care provider’s capacity for early recognition of cervical
cancer symptoms and establishing timely referral mech-
anism for diagnosis.
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